No Record Found
Sector
PharmaceuticalsOpen
₹4.5Prev. Close
₹4.5Turnover(Lac.)
₹0Day's High
₹4.5Day's Low
₹4.552 Week's High
₹052 Week's Low
₹0Book Value
₹-0.55Face Value
₹5Mkt Cap (₹ Cr.)
2.71P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -3.35 | -3.21 | -3 | -3 |
Net Worth | -0.34 | -0.2 | 0 | 0 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Revenue | 0 | 0 | 0.06 | 0.03 |
yoy growth (%) | 0 | -100 | 91.58 | -57.78 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | 0 | 0 | 0 | 0 |
Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Profit before tax | -0.07 | -0.01 | -0.05 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -0.04 | 0.14 | -0.06 | 0.02 |
Other operating items |
Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | -100 | 91.58 | -57.78 |
Op profit growth | 108.25 | -15.78 | -1,227.9 | -81.97 |
EBIT growth | 315.55 | -66.02 | -1,227.9 | -81.97 |
Net profit growth | 314.16 | -65.9 | -1,514.38 | -82.15 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,586.55 | 78.42 | 3,90,611.73 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 5,690.3 | 67.03 | 1,56,589.3 | 557 | 0.51 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,498.95 | 23.61 | 1,21,954.71 | 1,303.13 | 1.06 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,563.5 | 60.14 | 1,19,555.56 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,252.75 | 15.44 | 1,06,396.56 | 2,961.2 | 0.63 | 7,788.7 | 345.74 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman(Non Exe)&Dir(Non-Ind)
ILA RAJENDRA PATHAK
Managing Director
Amit Mukeshbhai Shah
Executive Director & CFO
Surbhit Shah
Independent Non Exe. Director
Dhruval Patel
Independent Non Exe. Director
Chetanbhai Patel
Independent Director
Nilesh Harkesh Yadav
Company Sec. & Compli. Officer
Deepak Khandelwal
328 Paradise Complex,
Sayajigunj,
Gujarat - 390005
Tel: 91-265-2362966
Website: http://www.rekvinalaboratories.com
Email: rekvina@gmail.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Rekvina Labs Ltd was incorporated on 1st November 1988. The Company is registered in England and Wales as a Public Limited Company. The company is mainly engaged in manufacturing and marketing of phar...
Read More
Reports by Rekvina Labs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.